MedPath

Development and Validation of a NIRS-based Sinusitis Screening

Completed
Conditions
Sinusitis
Interventions
Device: Optic imaging use near-infrared trans-illumination methods
Registration Number
NCT01485484
Lead Sponsor
University of California, Irvine
Brief Summary

The research at University of California Irvine, Beckman laser institute and Praxis Biosciences Incorporation, develope near-infrared trans-illumination methods. The optical imaging tool that can determine acute sinusitis and the response to treatment therapy.

Detailed Description

In the United States, approximately one in seven people develop sinusitis each year, and 20 million cases of acute bacterial sinusitis become chronic to require medical treatment. The optic light from the illumination wand travelled through the pallet into the sinuses and exited the face. The optic device can determine air-filled and fluid/tissue-filled spaces in the sinus cavity during clinical exam.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
161
Inclusion Criteria
  • Male or female 18 years of age and older
  • Subject with normal sinus
  • Subject who has been diagnosed and confirm by their physician
Exclusion Criteria
  • Younger than 18 years old
  • Pregnant women

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
SinusOptic imaging use near-infrared trans-illumination methodsOptic imaging use near-infrared trans-illumination methods
Primary Outcome Measures
NameTimeMethod
Sinus Healthup to 4 weeks

Assessment of sinusitis

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

UCI Beckman Laser Medical Clinic

🇺🇸

Irvine, California, United States

© Copyright 2025. All Rights Reserved by MedPath